Edition:
United States

Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

10.66USD
18 Sep 2017
Change (% chg)

$-0.20 (-1.84%)
Prev Close
$10.86
Open
$10.85
Day's High
$10.87
Day's Low
$10.36
Volume
91,794
Avg. Vol
63,452
52-wk High
$12.04
52-wk Low
$4.89

Chart for

About

Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company's segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to... (more)

Overall

Beta: 0.89
Market Cap(Mil.): $493.48
Shares Outstanding(Mil.): 46.29
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 30.02 16.21
EPS (TTM): -- -- --
ROI: -- 6.62 14.56
ROE: -- 10.44 13.83

BRIEF-Enzo Biochem files for mixed shelf of up to $150 million ‍​

* Files for mixed shelf of up to $150 million - SEC filing ‍​ Source text for Eikon: Further company coverage:

Sep 01 2017

BRIEF-Enzo Biochem says federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences v. Abbott Laboratories ​

* Enzo Biochem says ‍a federal judge in a U.S. Court has entered an order in action entitled Enzo Life Sciences, Inc. v. Abbott Laboratories - sec filing​

Aug 16 2017

BRIEF-Enzo Biochem announces NY state health department approval of New Women’S Health Diagnostics

* Enzo Biochem announces New York State Health Department approval of new Women’s Health Diagnostics

Jun 08 2017

Earnings vs. Estimates